| Product Name |
Irinotecan Inhouse Impurity 3 / Irinotecan Keto Impurity
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals |
| CAS No |
176515-52-9 |
| Catalog Number |
GS.22.IRL.33 |
| Chemical Name/Synonyms |
10-Ethyl-2-methyl-3-propionyl-8-[(4-piperidinopiperidino) carbonyloxy] indolizino [1,2-b] quinoline-1-(11H )-one ; 12-Ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate ; [1,4'-Bipiperidine]-1'-carboxylic Acid 12-ethyl-9,11-dihydro-8-methyl-9-oxo-7-(1-oxopropyl)indolizino[1,2-b]quinolin-2-yl Ester |
| Molecular Weight |
542.66999999999996 |
| Molecular Formula |
C32H38N4O4 |
| Purity |
NLT 95 % |
| Applications |
Irinotecan Hydrochloride Trihydrate main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen FOLFIRI, which consists of infusional 5-fluorouracil, leucovorin, and irinotecan. |
| Inventory Status |
customized
|
